Raymond James Financial
BBNX

Raymond James Financial’s Beta Bionics BBNX Stock Holding History

Raymond James Financial’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-188,883
Closed -$1.86M – 5615
2026
Q1 		$1.86M Sell
188,883
-9,056
-5% -$134K ﹤0.01% 3415
2025
Q4 		$6.32M Sell
197,939
-6,353
-3% -$170K ﹤0.01% 2319
2025
Q3 		$4.06M Sell
204,292
-12,057
-6% -$212K ﹤0.01% 2616
2025
Q2 		$3.15M Buy
+216,349
New +$3.06M ﹤0.01% 2721

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Raymond James Financial's BBNX Position: Q2 2026 in Review

Raymond James Financial sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 188,883 shares — an estimated $1.86M sold.

Raymond James Financial first reported a position in BBNX in Q2 2025 and held it in 4 quarters. The position peaked at $6.32M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Raymond James Financial reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • Raymond James Financial sold 188,883 Beta Bionics shares in Q2 2026, an estimated $1.86M.
  • Raymond James Financial first reported a position in Beta Bionics in Q2 2025 and held it in 4 quarters.
  • Raymond James Financial's Beta Bionics position peaked at $6.32M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.